Immunotherapy in the treatment of advanced prostate cancer
Bob Djavan1, Kathleen Nelson2, Amir Kazzazi1, Aron Bruhn1, Helen Sadri1, Alejandro Gomez-Pinillos3, Anna C. Ferrari3
Canadian Journal of Urology, Vol.18, No.5, pp. 5865-5874, 2011
Abstract Prostate cancer is a complex disease, and treatment
selection is informed by numerous variables depending
on the stage of disease. Moreover, patient expectations
and the impact of treatment-related adverse events may
infl uence treatment choices. Available treatment options
over the course of the disease have included surgery,
radiation therapy, hormonal therapy, immunotherapy,
and chemotherapy. This complexity requires an
understanding of a wide range of treatment options and
the support of a multidisciplinary team that involves
urologists, radiation oncologists, diagnostic radiologists,
pathologists, and medical oncologists. Collaboration
among these physicians allows for a comprehensive
treatment strategy that… More >